Isomorphic Labs

Isomorphic Labs is an Alphabet-owned AI drug discovery company spun out of DeepMind in 2021.

1 article
Last mentioned

Isomorphic Labs is an Alphabet-owned drug discovery company founded in 2021 as a spinout of DeepMind, now Google DeepMind. DeepMind co-founder Demis Hassabis also serves as its chief executive, and the company is based in London.

It uses AI to predict protein structures and interactions between molecules in search of drug candidates, and it developed the protein structure prediction model AlphaFold 3 together with Google DeepMind.

This entry is based on AIPOST articles and widely known facts. If something is wrong, please send us a correction request.

Articles covering this entry

Partners include Meta, Google DeepMind and Isomorphic Labs, a drug discovery company spun out of Google DeepMind.


© 2026 AIPOST. All rights reserved.

AIPOST is an AI publication covering practical AI, AI security, performance, startups, health, ethics and industry news. No account is needed, and our privacy policy explains how we handle personal information.